COMBACTE open call

News & Events

The EFPIA view

COMBACTE open call

23.03.15

The COMBACTE open call is an opportunity for clinical trial programs or studies to join the COMBACTE project. The open call aims to identify potential replacement antimicrobial agents or approaches developed by EFPIA companies that could fulfill the overall objectives of the project i.e. to conduct prospective clinical trials with novel trial designs to deliver safety, pharmacology, and proof of efficacy data for novel agents directed towards treatment, prevention or sequelae of infections due to priority pathogens.

COMBACTE is one of the first IMI projects to be launched under the ND4BB programme with the aim of developing a broad European network of fully capable and Good Clinical Practice (GCP) compliant clinical investigation sites associated to microbiological labs to execute clinical trials enabling the registration of novel agents to be used in the treatment of patients with bacterial infections. Following the early termination of development of GSK1322322, the first novel agent to be developed within COMBACTE, there is now opportunity for other clinical trial programs or studies to join the COMBACTE project.

The deadline for submissions for the open call is 29th April 2015, 1900 CET. The open call protocol and guidelines for submitting proposals to the COMBACTE project can be found by clicking here and the COMBACTE proposal submission template and evaluation criteria by clicking here.
There will be a webinar on the call topic which will give potential partners an opportunity to learn more about COMBACTE and ask questions. Details will be the subject of a future announcement posted on the COMBACTE website.